Inhibiting CDK1 overcomes oxaliplatin resistance in CRC by regulating acyl-CoA synthetase long-chain family member 4 (ACSL4)-mediated ferroptosis (Chen et al., 2015). This evidence concerns the gene ACSL4 and colorectal carcinoma.